Crown Bioscience
Crown Bioscience is a global contract research organization (CRO) specializing in preclinical and translational drug discovery solutions. The company provides comprehensive services in oncology, immuno-oncology, and immunology, supporting pharmaceutical and biotechnology clients worldwide. Crown Bioscience’s portfolio includes advanced in vitro, in vivo, and ex vivo models, as well as cutting-edge bioinformatics and biomarker analysis. By leveraging scientific expertise and innovative technologies, Crown Bioscience accelerates the development of novel therapeutics, enabling clients to make informed decisions in drug development. The company is committed to delivering high-quality, reliable data to advance research and improve patient outcomes across multiple therapeutic areas.
